wibbitz

Study Suggests Ketamine Therapy , Could Help Treat Anxiety & Depression.
According to recent study, ketamine infusion
therapy was linked to a reduction in self-reported
symptoms of anxiety, depression and suicidal thoughts.
According to recent study, ketamine infusion
therapy was linked to a reduction in self-reported
symptoms of anxiety, depression and suicidal thoughts.
PsyPost reports that the study provides insight into the
effectiveness of ketamine therapy and evidence that
it could result in lasting and significant improvements.
The study was published in the
'Journal of Affective Disorders.' .
I am interested in this topic because
as ketamine intravenous therapy has
not been FDA approved for depression,
there have been few randomized
controlled trials to assess the efficacy
and safety of this treatment, Alison McInnes, the Vice President of
Scientific Affairs at Osmind, via PsyPost.
Therefore, it is essential that we
generate real-world evidence from
patients treated with ketamine
intravenous therapy in community settings
to convince insurers that the treatment
is effective and should be covered, Alison McInnes, the Vice President of
Scientific Affairs at Osmind, via PsyPost.
According to the team's results,
a significant number of patients
responded to the treatment. .
Over 49% of patients responded for
depression, while another 47.5% of
participants responded for anxiety.
PsyPost reports that the reduction
in symptoms was significant
both statistically and clinically. .
The results of the study found that intravenous ketamine
treatments had a greater impact on depression
than standard antidepressant monotherapy.
Ketamine intravenous therapy has
a robust effect size for treatment
resistant depression and for anxiety, Alison McInnes, the Vice President of
Scientific Affairs at Osmind, via PsyPost

KetamineTherapyInfusionDepressionAnxietySuicideTreatmentSymptomImprovementMental Health